(Q22255557)

8 February 2023

F. Soldani

series ordinal

author given names

Federico

author last names

Soldani

1 reference

8 February 2023

L. Tondo

series ordinal

author given names

Leonardo

author last names

Tondo

1 reference

8 February 2023

R. J. Baldessarini

series ordinal

author given names

Ross J

author last names

Baldessarini

1 reference

British Journal of Psychiatry

8 February 2023

language of work or name

English

0 references

publication date

30 June 2008

0 references

published in

0 references

volume

193

0 references

issue

0 references

page(s)

10-17

0 references

cites work

Psychotropic practice patterns for youth: a 10-year perspective

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Imipramine in prepubertal major depressive disorders

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

A Double-blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Children and Adolescents With Depression

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Suicidal Risk in Antidepressant Drug Trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Suicidality in pediatric patients treated with antidepressant drugs

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Trends in the prescribing of psychotropic medications to preschoolers

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Tricyclic drugs for depression in children and adolescents.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Adolescent depression: controlled desipramine treatment and atypical features

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Clinical effects of amitriptyline in adolescent depression. A pilot study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Are child-, adolescent-, and adult-onset depression one and the same disorder?

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Treatment of depression in children and adolescents

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Biological studies in depressed children and adolescents

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

ACNP Task Force report on SSRIs and suicidal behavior in youth

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Expanding the black box - depression, antidepressants, and the risk of suicide

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Predicting desipramine levels in children and adolescents: a naturalistic clinical study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Analog classroom assessment of Adderall in children with ADHD.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

1 reference

7 January 2021

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Fluoxetine pharmacokinetics in pediatric patients

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Placebo Response and Antidepressant Clinical Trial Outcome

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Review of the efficacy and safety of antidepressants in youth depression

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Efficacy and safety of antidepressants for children and adolescents

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Rethinking childhood depression

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Wishful thinking: antidepressant drugs in childhood depression

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Perspectives on the efficacy of antidepressants for child and adolescent depression

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.106.031088

7 January 2021

10.1192/BJP.BP.106.031088

Identifiers

DOI

0 references

Fatcat ID

release_h5fagc37mvalxp3m536zn6qpxu

0 references